These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy. Kanbayashi T, Honda K, Kodama T, Mignot E, Nishino S. Neuroscience; 2000; 99(4):651-9. PubMed ID: 10974428 [Abstract] [Full Text] [Related]
3. Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Nishino S, Mao J, Sampathkumaran R, Shelton J. Sleep Res Online; 1998; 1(1):49-61. PubMed ID: 11382857 [Abstract] [Full Text] [Related]
4. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Boutrel B, Koob GF. Sleep; 2004 Sep 15; 27(6):1181-94. PubMed ID: 15532213 [Abstract] [Full Text] [Related]
5. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. Okuro M, Fujiki N, Kotorii N, Ishimaru Y, Sokoloff P, Nishino S. Sleep; 2010 Jul 15; 33(7):930-42. PubMed ID: 20614853 [Abstract] [Full Text] [Related]
6. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. Cell; 1999 Aug 20; 98(4):437-51. PubMed ID: 10481909 [Abstract] [Full Text] [Related]
7. Wake-promoting effects of ONO-4127Na, a prostaglandin DP1 receptor antagonist, in hypocretin/orexin deficient narcoleptic mice. Sagawa Y, Sato M, Sakai N, Chikahisa S, Chiba S, Maruyama T, Yamamoto J, Nishino S. Neuropharmacology; 2016 Nov 20; 110(Pt A):268-276. PubMed ID: 27474349 [Abstract] [Full Text] [Related]
9. Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. Qu WM, Huang ZL, Xu XH, Matsumoto N, Urade Y. J Neurosci; 2008 Aug 20; 28(34):8462-9. PubMed ID: 18716204 [Abstract] [Full Text] [Related]
13. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat. Edgar DM, Seidel WF. J Pharmacol Exp Ther; 1997 Nov 20; 283(2):757-69. PubMed ID: 9353396 [Abstract] [Full Text] [Related]
14. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs. Shelton J, Nishino S, Vaught J, Dement WC, Mignot E. Sleep; 1995 Dec 20; 18(10):817-26. PubMed ID: 8746387 [Abstract] [Full Text] [Related]
16. Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat. Wisor JP, Dement WC, Aimone L, Williams M, Bozyczko-Coyne D. Pharmacol Biochem Behav; 2006 Nov 20; 85(3):492-9. PubMed ID: 17134745 [Abstract] [Full Text] [Related]
18. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice. Fujiki N, Cheng T, Yoshino F, Nishino S. Exp Neurol; 2009 May 20; 217(1):46-54. PubMed ID: 19416673 [Abstract] [Full Text] [Related]
19. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. Morón JA, Brockington A, Wise RA, Rocha BA, Hope BT. J Neurosci; 2002 Jan 15; 22(2):389-95. PubMed ID: 11784783 [Abstract] [Full Text] [Related]